• Cirrhosis is a chronic condition characterized by diffuse replacement of liver cells by fibrotic tissue, which creates a nodular-appearing distortion of the normal liver architecture. Advanced fibrosis represents the end result of many etiologies of liver injury.
  • Cirrhosis affects nearly 5.5 million Americans. In 2009, it was the 12th leading cause of death in the US.1
  • The most common etiologies are alcohol-related liver disease, chronic viral infection, and NAFLD (diagnosis and treatment discussed earlier in respective sections).
  • Main complications of cirrhosis include portal hypertension with various clinical manifestations (ascites, esophageal and gastric varices, portal hypertensive gastropathy (PHG) and colopathy, hypersplenism, gastric antral vascular ectasia, spontaneous bacterial peritonitis [SBP], hepatorenal syndrome [HRS], hepatic encephalopathy, and HCC). Frequent laboratory abnormalities encountered in a patient with cirrhosis include anemia, leukopenia, thrombocytopenia, hypoalbuminemia, coagulopathy, and hyperbilirubinemia.

There's more to see -- the rest of this topic is available only to subscribers.